Cantor Fitzgerald Analysts Boost Earnings Estimates for RIGL

Cantor Fitzgerald Analysts Boost Earnings Estimates For RIGL

1 week from now

1 day ago  · Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will earn $0.33 per share for the year, up from their previous forecast of $0.19. Cantor Fitzgerald currently has a "Neutral" rating and a $25.00 target price on the stock. The consensus …

marketbeat.com

Rigel Pharmaceuticals (NASDAQ:RIGL) Stock, Analyst Ratings, Price ...

1 week from now

The latest price target for Rigel Pharmaceuticals (NASDAQ:RIGL) was reported by Cantor Fitzgerald on December 10, 2024. The analyst firm set a price target for $25.00 expecting …

benzinga.com

Rigel Pharmaceuticals Inc. Q4 Earnings Summary - Markets Insider

1 week from now

Mar 5, 2024  · (RTTNews) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL): Earnings: $0.74 million in Q4 vs. $1.40 million in the same ...

businessinsider.com

Cantor Fitzgerald Issues Positive Forecast For Rigel Pharmaceuticals ...

1 week from now

Dec 11, 2024  · Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its target price lifted by Cantor Fitzgerald from $15.00 to $25.00 in a research report released on Tuesday …

etfdailynews.com

Rigel Pharmaceuticals Price Target Raised To $25 From $15 At …

1 week from now

Dec 10, 2024  · Cantor Fitzgerald raised the firm’s price target on Rigel Pharmaceuticals (RIGL) to $25 from $15 and keeps a Neutral rating on the shares. Rigel announced initial data from the …

nasdaq.com

Cantor Fitzgerald Remains A Hold On Rigel (RIGL)

1 week from now

Dec 10, 2024  · In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Hold rating on Rigel (RIGL – Research Report), with a price target of $25.00. The company’s …

businessinsider.com

Rigel Pharmaceuticals Inc. Q3 Earnings Summary - Markets Insider

1 week from now

Nov 7, 2024  · (RTTNews) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL): Earnings: $12.42 million in Q3 vs. -$5.69 million in the same period last year. EPS: …

businessinsider.com

Rigel Pharmaceuticals' SWOT Analysis: Stock Poised For Growth …

1 week from now

Dec 13, 2024  · Cantor Fitzgerald: Neutral rating with a price target of $15.00 (August 7th, 2024) This analysis is based on information available up to December 13, 2024, and reflects the …

investing.com

Cantor Fitzgerald Boosts Rigel Pharmaceuticals (NASDAQ:RIGL) …

1 week from now

Dec 13, 2024  · Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its target price hoisted by Cantor Fitzgerald from $15.00 to $25.00 in a report published on Tuesday,Benzinga …

americanbankingnews.com

HC Wainwright Issues Positive Forecast For Applied Digital

1 week from now

1 day ago  · Finally, Cantor Fitzgerald lowered their price target on shares of Applied Digital from $15.00 to $14.00 and set an "overweight" rating for the company in a report on Wednesday. ...

marketbeat.com